NCT00218192View on ClinicalTrials.gov

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

PHASE3CompletedINTERVENTIONAL

Enrollment

277

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

HCV Negative StatusHCV Risk Behavior

Interventions

BEHAVIORAL

Behavior Therapy

Trial Locations (1)

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

Butler Hospital

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Butler Hospital

OTHER